Intellia Therapeutics Inc (NTLA)
21.56
-0.29
(-1.33%)
USD |
NASDAQ |
Apr 23, 16:00
21.66
+0.10
(+0.46%)
After-Hours: 20:00
Intellia Therapeutics Total Liabilities (Quarterly): 250.81M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 250.81M |
| September 30, 2023 | 205.94M |
| June 30, 2023 | 218.35M |
| March 31, 2023 | 227.05M |
| December 31, 2022 | 284.53M |
| September 30, 2022 | 259.51M |
| June 30, 2022 | 229.88M |
| March 31, 2022 | 249.03M |
| December 31, 2021 | 254.22M |
| September 30, 2021 | 227.86M |
| June 30, 2021 | 177.43M |
| March 31, 2021 | 171.02M |
| December 31, 2020 | 149.25M |
| September 30, 2020 | 128.94M |
| June 30, 2020 | 139.24M |
| March 31, 2020 | 66.99M |
| December 31, 2019 | 64.40M |
| Date | Value |
|---|---|
| September 30, 2019 | 70.98M |
| June 30, 2019 | 75.58M |
| March 31, 2019 | 80.02M |
| December 31, 2018 | 69.40M |
| September 30, 2018 | 57.96M |
| June 30, 2018 | 60.44M |
| March 31, 2018 | 64.05M |
| December 31, 2017 | 75.64M |
| September 30, 2017 | 73.32M |
| June 30, 2017 | 77.39M |
| March 31, 2017 | 79.38M |
| December 31, 2016 | 89.13M |
| September 30, 2016 | 83.34M |
| June 30, 2016 | 87.02M |
| March 31, 2016 | 102.68M |
| December 31, 2015 | 103.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
64.40M
Minimum
Dec 2019
284.53M
Maximum
Dec 2022
181.63M
Average
205.94M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Moderna Inc | 4.572B |
| Regeneron Pharmaceuticals Inc | 7.107B |
| NeuroMetrix Inc | 1.333M |
| Repligen Corp | 853.21M |
| Pacific Biosciences of California Inc | 1.045B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.301B |
| Shareholders Equity (Quarterly) | 1.050B |
| Current Ratio | 8.666 |